Affiliation:
1. Temple University School of Pharmacy, Philadelphia, PA, USA
2. Institute for Safe Medication Practices, Horsham, PA, USA
Abstract
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: mmancano@temple.edu ). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA’s MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.
Subject
Pharmacology (medical),Pharmacology,Pharmacy
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiotoxicity of Commonly Used Drugs in HSCT;Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation;2024
2. Rhabdomyolyse unter Behandlung mit Venlafaxin und Risperidon;Der Nervenarzt;2019-12-02